See more on the 2013 NHSScotland Event website http://www.nhsscotlandevent.com/resources/resources2013/resources

1. Health Innovation Partnership
(Medical Technologies)
NHSScotland and Scottish life
sciences – joined at the HIP
Scott Johnstone HIP Industry Liaison

2. Statement Of Intent For
Innovation In Health
• Health And Wealth In Scotland: Statement Of
Intent For Innovation In Health Basis For NHS-
Industry Engagement
• Launched By Cabinet Secretary for Health in June
2012 at this event
• Statement Was Put Together With Extensive
Industry Involvement – Government and NHS
Reached Out
• Early Days – But Already Significant Progress

3. Statement Of Intent For Innovation In Health
2020 Vision for Health and Care in Scotland:
We will have a world-leading healthcare service
where everyone is able to live longer and healthier
lives at home, or in a homely setting.
STATEMENT OF INTENT FOR INNOVATION IN
HEALTH
Life Sciences Scotland Strategy
Our ambition is to double the economic contribution
of Life Sciences to the Scottish economy by 2020.

4. Statement Of Intent For
Innovation In Health
Achieving the Quality Ambitions and
delivering the 20:20 Vision and the Life
Sciences Strategy requires innovation
and engagement with the life sciences
industries to help identify, develop and
adopt innovations that address the
quality challenges facing the NHS now
and in future.

5. Statement Of Intent For
Innovation In Health
• NHSScotland will build strategic partnerships with
life sciences businesses to make this happen.
• NHSScotland will extend its role as a driver for
growth in the life sciences and related health
industries and the wider economy in Scotland
through more effective use of innovation.
• NHSScotland will work in concert with others to
make sure that ‘Scotland PLC’ is competitive.
• Industry and research will pursue innovative
solutions that address identified future
requirements of NHSScotland.

6. Health Innovation Partnership
(Medical Technologies)
Already Starting To Happen
•The Health Innovation Partnership (Medical
Technologies)
•NHS and Industry working together to identify
mutual benefits – 11 projects so far
•Currently focused upon products at or near market
•Will increasingly look at next generation of
innovations – the real ‘Win-Wins
•Similar partnerships to develop in digital health
and medicines

7. HIP Ambitions
•Higher quality care and more effective and
efficient interventions
•Increased sustainability and efficiency for
NHSScotland’s services
•Life sciences products that have stronger market
potential because they are focussed upon the
needs of health services in Scotland and beyond.
•Industry and research will pursue innovative
solutions that address future requirements of
NHSScotland.

8. HIP Challenges
• Defining future needs for NHS and picking priorities
• Tackling barriers to adoption and spread of technology
• Getting NHS and business to move from current
pressures to future opportunities
• Interface between NHS and companies
• Procurement (NHS does not need every ‘innovative’
product on the market)
• Developing evidence on innovation through health
technology assessments

9. Health Innovation Partnership
(Medical Technologies)
Already some real examples of mutual benefit
from HIP (Medical Technologies)
• company getting told early by the NHS that its
technology idea isn’t needed!
• company being told that if its device could do
a different task instead of or as well as the
initial idea, then it would be much more
useful

10. Health Innovation Partnership
(Medical Technologies)
But if
• a company is told that the NHS really needs
its idea;
• clinicians then get involved with trials
• real partnership evolves as a result
that can transform its investment and
commercial potential as a business! (as well as
deliver a benefit to NHS)

11. Health Innovation Partnership
(Medical Technologies)
Company Application
Alba BioScience Automated Blood Typing
Anacail Ozone based Sterilisation Technology
Cytosystems Bladder Cancer Diagnostics
Lamellar BioMedical Mimicry of human lamellar bodies
Omega Critical Care Invasive Heart Monitor
Point-2-Point Genomics Fast PCR Multiplexing
Softcell Tissue Monitoring
Toshiba (TMVSE) Access to radiological reading rooms
Touch Bionics Scottish Evaluation of bionic hand
UWI Time sensitive label technology

12. Health Innovation Partnership
(Medical Technologies)
Example – Lamellar Biomedical
• 3 planned clinical trials with lead product LMS 611
• Working with clinicians at
– The Beatson West of Scotland cancer Centre
– Vision Sciences at Glasgow Caledonian University
– Adult CF clinic at the Gartnavel Hospital
• Support of key opinion leaders crucial in raising funds
• Possibility exists to create clinical and commercial success
in Scotland
• NHS Scotland can become a competitive advantage cf the
Mayo Clinic, Memorial Sloane Kettering and Fred
Hutchinson in the US

13. Health Innovation Partnership
(Medical Technologies)
QUESTIONS
(for you!)